Steris Plc has seen a fluctuating performance in recent times, with instances of underperformance and outperformance against competitors. Despite this volatility, it has shown a trend of earnings growth, as indicated by its Q1 and Q2 results, which have beaten estimates. The company has declared a
quarterly dividend of $0.57 per share and is expected to announce its Q3 earnings soon. Steris has seen considerable activity from investment firms; abrdn Plc and Assenagon Asset Management increased their stake in the company, while Allspring Global Investments Holdings reduced its stake. Significant business moves include the sale of the dental unit to HuFriedy, focusing on
debt reduction, and the suggestion of a future CEO salary increase. However, the company's decision to undergo restructuring, resulting in layoffs and closure of plants in Brazil and England, caps off the mixed sentiments.
Steris Plc STE News Analytics from Wed, 05 Dec 2018 08:00:00 GMT to Fri, 01 Nov 2024 22:07:00 GMT -
Rating -3
- Innovation -1
- Information 7
- Rumor -2